Table 1.
Top 20 genes (siRNAs significantly potentate CDDO-Me in A375 cells | Description | p- Value (1 × 10−4) | Fold Changes |
---|---|---|---|
GNPAT | Glyceronephosphate O-acyltransferase | 2.82 | 7.48 |
SUMO1 | SMT3 suppressor of inif two 3 homolog 1 (S. cerevisiae) | 5.74 | 4.23 |
HOXC9 | Homeabox C9 | 1.02 | 3.49 |
SPINT2 | Serine peptidase inhibitor. Kunitz type, 2 | 1.24 | 3.32 |
HLCS | Holocarboxylase synthelase | 5.77 | 3.30 |
GMPR | Guanosine monophosphate reductase | 4.67 | 3.08 |
FLII | Friend leukemia virus integration 1 | 3.61 | 3.07 |
SSX1 | Synovial sarcoma, X breakpoint 1 | 2.89 | 2.99 |
FOXK2 | Forkhead box- K2 | 3.68 | 2.33 |
ATP2A2 | ATPaxe, Ca2- Iransporimg cardiac, muscle, slow switch 2 | 3.00 | 2.31 |
PDCD61P | Programmed cell death 6 interacting protein | 0.781 | 2.07 |
ITGAX | Itegrin, alpha X (complement component 3 receptor & subunit) | 2,02 | 1.94 |
IRX4 | Iroquois homeobox 4 | 4.99 | 1.87 |
RBPSUIIL | Recombination signal binding protein for immunoglobulin kappa J region-like | 0.502 | 1.76 |
KIF5A | Kinesin family member 5A | 3.81 | 1.72 |
NKX2-8 | NK2 homoebox 8 | 5.49 | 1.54 |
UPP1 | Uridine, phosphorylase 1 | 4.52 | 1.52 |
SETDB1 | SET domain, bifurcated 1 | 2.70 | 1.48 |
SLX1 | SLX1 homeobax 1 | 4.39 | 1.38 |
II2AFY | II2A histone family, member Y | 4 63 | 1.31 |
Top general molecular and cellular function for 35 genes identify by siRNA screen | IPAp-Value | Number of identified genes |
---|---|---|
Cell death | 1.49 × 10−3–4.71 × 10−2 | 5 |
Cell niLiiphalugv | 1.49 × 10−3–3.95 × 10−2 | 3 |
Cellular assembly and organization | 1.49 × 10−3–3.37 × 10−2 | 4 |
Cellular growth und. prolifeiiition | 1.49 × 10−3–4.66 × 10−2 | 4 |
DNA repication and repair | 1.49 × 10−3–2.98 × 10−2 | 1 |
Top interaction signaling networks for 35 genes identify by siRNA screen | IPA Score | Number of identified genes |
---|---|---|
Cell development, cell growth and proliferation | 11 | 15 |
Developmental disorder | ||
Organismal development | 2~3 | 3 |
Nervous system development, and function | ||
Tissue morphology | ||
Reproductive system development and function | ||
Visual system development and function | ||
Metabilic disease | 2 | 1 |
Genetic disorder | ||
Lipid metabolism |